Annual ROE
-36.14%
+482.96%+93.04%
31 December 2023
Summary:
CytoMed Therapeutics Limited annual return on equity is currently -36.14%, with the most recent change of +482.96% (+93.04%) on 31 December 2023. During the last 3 years, it has risen by +354.13% (+90.74%). GDTC annual ROE is now at all-time high.GDTC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDTC ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +93.0% | - |
| 3 y3 years | +90.7% | - |
| 5 y5 years | - | - |
GDTC ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +93.0% | ||
| 5 y | 5 years | at high | +93.0% | ||
| alltime | all time | at high | +93.0% |
CytoMed Therapeutics Limited ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -36.14%(-93.0%) | - |
| Dec 2022 | -519.10%(+551.7%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -79.65%(-79.6%) | - |
| Dec 2020 | -390.27% | - |
FAQ
- What is CytoMed Therapeutics Limited annual return on equity?
- What is the all time high annual ROE for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual ROE year-on-year change?
What is CytoMed Therapeutics Limited annual return on equity?
The current annual ROE of GDTC is -36.14%
What is the all time high annual ROE for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual return on equity is -36.14%
What is CytoMed Therapeutics Limited annual ROE year-on-year change?
Over the past year, GDTC annual return on equity has changed by +482.96% (+93.04%)